Precigen
PGEN
166 hedge funds and large institutions have $978M invested in Precigen in 2021 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 67 increasing their positions, 27 reducing their positions, and 15 closing their positions.
148% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 27
107% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 15
10% more funds holding
Funds holding: 151 → 166 (+15)
4.73% more ownership
Funds ownership: 65.39% → 70.12% (+4.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
21% less capital invested
Capital invested by funds: $1.24B → $978M (-$258M)
23% less call options, than puts
Call options by funds: $5.28M | Put options by funds: $6.83M
Top Buyers
Top Sellers
PGEN Hedge Fund Activity: Q1 2021 in Review
166 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q1 2021, worth a combined $978M — down 21% from $1.24B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new PGEN positions and 15 closed out — a net gain of 16 holders — while 67 added to existing stakes and 27 trimmed.
The largest buyer was Iridian Asset Management, adding an estimated $58.7M. The largest seller was Susquehanna International Group, cutting an estimated $3.42M.
- 166 institutional investors held Precigen (PGEN) as of Q1 2021, up from 151 in Q4 2020.
- Funds reported $978M of Precigen stock for Q1 2021, down 21% quarter-over-quarter.
- 31 funds opened new Precigen positions in Q1 2021 and 15 closed out, a net change of +16 holders.
- The largest Precigen buyer in Q1 2021 was Iridian Asset Management, an estimated $58.7M added.
- The largest Precigen seller in Q1 2021 was Susquehanna International Group, an estimated $3.42M sold.
Based on aggregated 13F filings for Q1 2021.